Merck has announced that the U.S. FDA has approved Zinplava™ to reduce recurrence of C. diff infection. The drug was developed by researchers at MassBiologics in conjunction with Medarex (now part of Bristol-Myers Squibb), and licensed to Merck in 2009.
UMass Medical School has been identified as having one of the strongest university-based life sciences research enterprises in the world, according to the new National Taiwan University Ranking.
Spark Therapeutics and the Horae Gene Therapy Center have entered into a research collaboration to develop next generation viral vectors for gene therapy. Guangping Gao, PhD, will be the lead investigator at UMMS.
Kerstin Nündel, PhD, will examine how B cells, one of the immune system’s great defenses against infectious diseases, go haywire in some individuals, causing the organ damage which is the hallmark of lupus.
The winners of the Diabetes Innovation Challenge will be announced Thursday. The competition is being run in part by M2D2, a joint venture of UMass Lowell and UMass Medical School that incubates medical device start-ups.
UMass Medical School scientist and internationally recognized amyotrophic lateral sclerosis (ALS) researcher Robert H. Brown Jr., DPhil, MD, said he believes a breakthrough is within reach and explained his motivation in working to find it.
Academia is connecting with industry in a unique, new collaboration called the UMass Metabolic Network, in which scientists at UMass Medical School in Worcester will meet monthly to exchange ideas with peers from Pfizer in Cambridge.
A decade after UMass Medical School professor Craig C. Mello, PhD, was awarded the Nobel Prize in Medicine for the co-discovery of RNA interference (RNAi), therapies based on the science are nearing completion, according to a story in the Oct. 16 Worcester Telegram & Gazette.
In collaboration with four regional medical center groups, UMass Medical School will help to implement a prestigious precision medicine program aimed at individualizing disease prevention and treatment, according to the National Institutes of Health.
Celia Schiffer, PhD, has been selected by the Massachusetts Society for Medical Research as the recipient of the 2016 Mentoring Award for excellence in mentoring of STEM trainees. She will be recognized at the Society’s annual Biomedical Research Day Honors program on Oct. 21.